An Open-label Extension Study Evaluating the Safety and Efficacy of Upadacitinib (ABT-494) in Adults With Rheumatoid Arthritis
Clinical trial NCT02049138 · COMPLETED
Trial details
- NCT number
- NCT02049138
- Sponsor
- AbbVie
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-01-24
- Primary completion
- 2021-07-29
- Enrollment
- 493
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.